Shrimp peptide QMDDQ improves scopolamine-induced memory impairments by activating the Notch1 signaling pathway
Peng-Fei Yan,
No information about this author
Junchao Wang,
No information about this author
Xiyu Zhao
No information about this author
et al.
Food Bioscience,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106041 - 106041
Published: Feb. 1, 2025
Language: Английский
A single dose of haloperidol decanoate induces short-term hippocampal neuroinflammation: focus on the glial response
Pharmacological Reports,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
Language: Английский
Research Progress on Glial Cells in Neurodegenerative Diseases
Journal of Contemporary Medical Practice,
Journal Year:
2025,
Volume and Issue:
7(2), P. 18 - 23
Published: Feb. 28, 2025
This
review
discusses
glial
cells
in
neurodegenerative
diseases
as
represents
their
role
and
scientific
advances.
Glial
specifically
offer
support
to
neurons
all
fields
of
normal
functioning
while
also
participating
processes
such
damage
repair
under
pathological
minutiae.
The
article
the
above
with
respect
Alzheimer’s,
Parkinson’s,
multiple
sclerosis,
other
ailments
by
combining
latest
research
findings
discuss
potential
therapeutic
targets
intervention
avenues.
It
emphasizes
that
understanding
cell
functions
engages
can
be
critical
they
develop
novel
treatment
approaches
for
debilitating
conditions.
Language: Английский
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao,
No information about this author
Cheng‐Xiang Wang,
No information about this author
Chuan Zou
No information about this author
et al.
European Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
997, P. 177469 - 177469
Published: March 5, 2025
Language: Английский
Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte–microglia co-culture model
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
16
Published: March 18, 2025
Schizophrenia
is
a
severe
mental
disorder
with
strong
lifetime
impact
on
patients'
health
and
wellbeing.
Usually,
symptomatic
treatment
includes
typical
or
atypical
antipsychotics.
Study
findings
show
an
involvement
of
low-grade
inflammation
(blood,
brain
parenchyma,
cerebrospinal
fluid)
in
schizophrenia.
Moreover,
experimental
neuropathological
evidence
suggests
that
reactive
microglia,
which
are
the
main
resident
immune
cells
central
nervous
system
(CNS),
have
negative
differentiation
function
oligodendrocytes,
glial
progenitor
cells,
astrocytes,
results
disruption
neuronal
networks
dysregulated
synaptic
transmission,
contributing
to
pathophysiology
Here,
role
microglial
related
neuroinflammation
schizophrenia
was
discussed
be
essential.
This
review
aims
summarize
for
influence
antipsychotics
inflammatory
mechanisms
Furthermore,
we
propose
established
astrocyte-microglia
co-culture
model
testing
regulatory
examining
effects
glia-mediated
neuroinflammation.
could
lead
better
understanding
how
can
used
address
positive
symptoms
comorbidities
like
diseases
status
inflammation.
Language: Английский